Batesville Regional Medical Center, INC.
Batesville Regional Medical Center, INC. was paid $87K by Medicaid between Jan 2018 and Feb 2020, across 70 billing codes. Its largest line is 99283, emergency room visit (moderate) — 71% of everything it billed.
BATESVILLE, MS 38606
Next to other General Acute Care Hospital providers in Mississippi
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 426 | $45K | |
| 2019 | 18,073 | $39K | |
| 2020 | 2,856 | $3K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 71% | 1,232 | 695 | $62K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 11% | 645 | 364 | $10K |
| D7140 | Extraction, erupted tooth or exposed root | 6.2% | 480 | 90 | $5K |
| 41899 | Unlisted procedure, dentoalveolar structures | 1.9% | 560 | 315 | $2K |
| D0272 | Bitewings - two radiographic images | 1.5% | 71 | 40 | $1K |
| D2930 | Prefabricated stainless steel crown - primary tooth | 1.2% | 2,819 | 293 | $1K |
| D2934 | <1% | 399 | 70 | $838.25 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 264 | 143 | $766.68 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 418 | 221 | $668.20 |
| D3220 | Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction | <1% | 1,982 | 289 | $632.32 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 241 | 125 | $467.97 |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | <1% | 156 | 83 | $426.05 |
58 more codes
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 407 | $389.20 |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | <1% | 163 | $341.60 |
| D0220 | Intraoral - periapical first radiographic image | <1% | 99 | $205.27 |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 159 | $189.84 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 125 | $189.84 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 276 | $119.04 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 833 | $91.94 |
| 71046 | Radiologic examination, chest; 2 views | <1% | 23 | $50.72 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 226 | $45.51 |
| 80053 | Comprehensive metabolic panel | <1% | 759 | $43.45 |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 116 | $41.77 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 144 | $33.84 |
| D1120 | Dental cleaning, child | <1% | 176 | $30.12 |
| D1206 | Topical application of fluoride varnish | <1% | 188 | $22.42 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 216 | $17.94 |
| 84703 | <1% | 185 | $15.04 | |
| 87807 | <1% | 86 | $11.99 | |
| 81003 | <1% | 516 | $11.20 | |
| 87040 | <1% | 26 | $10.32 | |
| J3490 | Unclassified drugs | <1% | 249 | $0.22 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 1,509 | $0.00 |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 0% | 56 | $0.00 |
| 87653 | 0% | 27 | $0.00 | |
| 86900 | 0% | 21 | $0.00 | |
| 84702 | 0% | 124 | $0.00 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 0% | 179 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 44 | $0.00 |
| J7510 | Prednisolone oral, per 5 mg | 0% | 25 | $0.00 |
| 70450 | Computed tomography, head or brain; without contrast material | 0% | 33 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 24 | $0.00 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 0% | 19 | $0.00 |
| 80061 | Lipid panel | 0% | 59 | $0.00 |
| 87186 | 0% | 23 | $0.00 | |
| D9999 | Unspecified adjunctive procedure, by report | 0% | 579 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 839 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 750 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 616 | $0.00 |
| 84484 | 0% | 114 | $0.00 | |
| 71045 | Radiologic examination, chest; single view | 0% | 211 | $0.00 |
| 81001 | 0% | 29 | $0.00 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 0% | 43 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 57 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 974 | $0.00 |
| 83690 | 0% | 18 | $0.00 | |
| 85027 | 0% | 206 | $0.00 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 109 | $0.00 |
| 83735 | 0% | 70 | $0.00 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 86 | $0.00 |
| 59050 | 0% | 20 | $0.00 | |
| 86592 | 0% | 42 | $0.00 | |
| 94760 | 0% | 43 | $0.00 | |
| 87081 | 0% | 17 | $0.00 | |
| 86901 | 0% | 21 | $0.00 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 23 | $0.00 |
| 86850 | 0% | 18 | $0.00 | |
| D0230 | Intraoral - periapical each additional radiographic image | 0% | 25 | $0.00 |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 0% | 27 | $0.00 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 0% | 36 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Clarksdale Regional Physicians, LLC | Clarksdale, MS | $308K |
| Russellville Physicians LLC | Russellville, AL | $304K |
| Lakeland Physicians LLC | Haleyville, AL | $284K |
| Batesville Regional Physicians LLC | Batesville, MS | $202K |
| Amory Regional Medical Center, INC. | Amory, MS | $166K |
| Batesville Regional Medical Center, INC. | Batesville, MS | $15K |
| Clarksdale Regional Physicians, LLC | Clarksdale, MS | $15K |
| Amory Regional Physicians,llc | Amory, MS | $10K |
| Clarksdale Regional Physicians, LLC | Clarksdale, MS | $3K |
| Clarksdale Regional Medical Center, INC. | Clarksdale, MS | $2K |
| Batesville Regional Medical Center, INC. | Batesville, MS | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.